Arindam Bose

760 total citations
13 papers, 485 citations indexed

About

Arindam Bose is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Arindam Bose has authored 13 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Arindam Bose's work include DNA Repair Mechanisms (12 papers), DNA and Nucleic Acid Chemistry (6 papers) and CRISPR and Genetic Engineering (4 papers). Arindam Bose is often cited by papers focused on DNA Repair Mechanisms (12 papers), DNA and Nucleic Acid Chemistry (6 papers) and CRISPR and Genetic Engineering (4 papers). Arindam Bose collaborates with scholars based in United States and France. Arindam Bose's co-authors include Patricia L. Opresko, Hui-Ting Lee, Sua Myong, Ashis K. Basu, Robert W. Sobol, Jianfeng Li, Elise Fouquerel, Bret Freudenthal, Grace S. Kim and Paritosh Pande and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Cancer Research.

In The Last Decade

Arindam Bose

13 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arindam Bose United States 11 383 169 74 62 31 13 485
Ranga N. Venkatesan United States 8 279 0.7× 105 0.6× 95 1.3× 56 0.9× 38 1.2× 10 409
Avik K. Ghosh United States 9 363 0.9× 120 0.7× 78 1.1× 64 1.0× 32 1.0× 11 432
Corey Winston Jones-Weinert United States 7 371 1.0× 73 0.4× 40 0.5× 58 0.9× 27 0.9× 8 435
Zih-Jie Shen United States 8 322 0.8× 43 0.3× 65 0.9× 43 0.7× 17 0.5× 11 373
Zhi‐Xia Yang China 11 255 0.7× 51 0.3× 51 0.7× 37 0.6× 24 0.8× 25 427
Marcel Hohl United States 13 636 1.7× 54 0.3× 124 1.7× 120 1.9× 8 0.3× 16 678
Karolin Klement Germany 8 240 0.6× 63 0.4× 37 0.5× 59 1.0× 15 0.5× 10 297
Eleonora Petti Italy 8 259 0.7× 105 0.6× 147 2.0× 31 0.5× 12 0.4× 9 326
Adam G. Evertts United States 7 382 1.0× 77 0.5× 47 0.6× 46 0.7× 12 0.4× 8 456
Marija Vujcic United States 7 353 0.9× 27 0.2× 62 0.8× 32 0.5× 54 1.7× 8 397

Countries citing papers authored by Arindam Bose

Since Specialization
Citations

This map shows the geographic impact of Arindam Bose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arindam Bose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arindam Bose more than expected).

Fields of papers citing papers by Arindam Bose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arindam Bose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arindam Bose. The network helps show where Arindam Bose may publish in the future.

Co-authorship network of co-authors of Arindam Bose

This figure shows the co-authorship network connecting the top 25 collaborators of Arindam Bose. A scholar is included among the top collaborators of Arindam Bose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arindam Bose. Arindam Bose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bose, Arindam, Yuqing Jiao, Jean‐Bernard Lazaro, et al.. (2023). Abstract 6210: Combination of M1774 and niraparib can overcome ATR and PARP inhibitor resistance in BRCA1 mutated ovarian cancer models. Cancer Research. 83(7_Supplement). 6210–6210. 1 indexed citations
2.
Costa, Alexandre André Balieiro Anastácio da, Arindam Bose, Yuqing Jiao, et al.. (2023). Abstract 5725: The USP1 inhibitor I-138 kills BRCA1-deficient tumor cells and overcomes PARP inhibitor resistance. Cancer Research. 83(7_Supplement). 5725–5725. 1 indexed citations
3.
Patterson-Fortin, Jeffrey, Arindam Bose, Huy Nguyen, et al.. (2022). Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53 -Mutant Cancers. Cancer Research. 82(20). 3815–3829. 36 indexed citations
4.
Lee, Hui-Ting, et al.. (2020). Position-Dependent Effect of Guanine Base Damage and Mutations on Telomeric G-Quadruplex and Telomerase Extension. Biochemistry. 59(28). 2627–2639. 29 indexed citations
5.
Lee, Hui-Ting, Arindam Bose, Chun‐Ying Lee, Patricia L. Opresko, & Sua Myong. (2017). Molecular mechanisms by which oxidative DNA damage promotes telomerase activity. Nucleic Acids Research. 45(20). 11752–11765. 62 indexed citations
6.
Fouquerel, Elise, Arindam Bose, Hui-Ting Lee, et al.. (2016). Oxidative guanine base damage regulates human telomerase activity. Nature Structural & Molecular Biology. 23(12). 1092–1100. 148 indexed citations
7.
García-Expósito, Laura, Elodie Bournique, Valérie Bergoglio, et al.. (2016). Proteomic Profiling Reveals a Specific Role for Translesion DNA Polymerase η in the Alternative Lengthening of Telomeres. Cell Reports. 17(7). 1858–1871. 114 indexed citations
9.
Basu, Ashis K., Paritosh Pande, & Arindam Bose. (2016). Translesion Synthesis of 2′-Deoxyguanosine Lesions by Eukaryotic DNA Polymerases. Chemical Research in Toxicology. 30(1). 61–72. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026